4//SEC Filing
INGENITO GARY 4
Accession 0001161697-25-000089
CIK 0001369568other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:00 PM ET
Size
14.5 KB
Accession
0001161697-25-000089
Insider Transaction Report
Form 4
INGENITO GARY
Chief Med. & Reg. Officer
Transactions
- Sale
Common stock, par value $0.001 per share
2025-03-05$22.09/sh−44,904$991,929→ 68,873 total - Exercise/Conversion
Options to purchase common stock
2025-03-05−44,904→ 970,378 totalExercise: $2.24Exp: 2025-12-19→ Common Stock (44,904 underlying) - Exercise/Conversion
Common stock, par value $0.001 per share
2025-03-05$2.24/sh+44,904$100,585→ 113,777 total - Sale
Common stock, par value $0.001 per share
2025-03-06$21.67/sh−180,096$3,902,680→ 68,873 total - Exercise/Conversion
Options to purchase common stock
2025-03-06−180,096→ 790,282 totalExercise: $2.24Exp: 2025-12-19→ Common Stock (180,096 underlying) - Exercise/Conversion
Common stock, par value $0.001 per share
2025-03-06$2.24/sh+180,096$403,415→ 248,969 total
Footnotes (4)
- [F1]Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- [F2]Represents a weighted average price for the shares sold. Shares were sold in a range between $22.00 and $22.285 per share.
- [F3]Represents a weighted average price for the shares sold. Shares were sold in a range between $21.60 and $21.95 per share.
- [F4]Options vested in three annual tranches beginning on December 19, 2019.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001279473
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 5:00 PM ET
- Size
- 14.5 KB